Bariendo Company Profile

Background

Bariendo, established in 2023, is a healthcare company specializing in non-surgical weight loss solutions. The company's mission is to collaborate with leading physicians to democratize access to advanced weight loss procedures and medications, grounded in rigorous research. Bariendo aims to set the national gold standard for Endoscopic Sleeve Gastroplasty (ESG) by partnering exclusively with top-tier doctors who adhere to best practices.

Key Strategic Focus

Bariendo's strategic focus centers on providing comprehensive, minimally invasive weight loss treatments that combine medication and next-generation endoscopic interventions. The company's physician-supervised approach, coupled with remote monitoring technology, sets a new benchmark in obesity care. Bariendo targets individuals seeking effective, non-surgical weight loss solutions, offering services such as ESG Stomach Tightening®, Gastric Balloon, Revision of Prior Bariatric Surgery, and Weight Loss Medication programs.

Financials and Funding

Bariendo has successfully secured funding to support its growth and development:

Seed Round (July 2023): Raised $3.35 million from investors including 500 Global and SeaX Ventures.

Venture Equity (September 2024): Secured an additional $3.8 million in investment from SeaX Ventures and private investors.

The capital raised is intended to enhance Bariendo's technological platforms, expand its service offerings, and strengthen its market presence.

Technological Platform and Innovation

Bariendo distinguishes itself through its proprietary technologies and innovative methodologies:

ESG Stomach Tightening®: A non-surgical, minimally invasive, reversible procedure that significantly reduces stomach size, leading to an average weight loss of 18-20%. This same-day procedure offers durable results with minimal downtime.

Remote Monitoring Technology: Bariendo's smart web application personalizes the weight loss journey by managing appointments, providing personalized care, monitoring progress with smart scales, and offering extended support for 12 months.

Leadership Team

Bariendo's leadership comprises experienced professionals dedicated to advancing non-surgical weight loss solutions:

Petch Jirapinyo: Co-Founder, Chief Executive Officer, and Board Member.

Dr. Christopher C. Thompson: Co-Founder, Board Member, and Scientific Advisor. Inventor of ESG Stomach Tightening and Professor at Harvard Medical School.

Dr. Pichamol "Sigh" Jirapinyo: Co-Founder, Board Member, and Medical Director. Director of Bariatric Endoscopy Fellowship at Brigham and Women's Hospital and Assistant Professor at Harvard Medical School.

Charles Dinolfo: Chief Operating Officer.

Jessica Doyle: Chief Marketing Officer.

Competitor Profile

Market Insights and Dynamics:

The non-surgical weight loss industry is experiencing significant growth, driven by increasing demand for minimally invasive procedures and effective weight management solutions. Advancements in endoscopic technologies and a focus on patient-centric care contribute to the industry's expansion.

Competitor Analysis:

Bariendo operates in a competitive landscape with several key players:

Calibrate: Offers a comprehensive weight loss program combining medication, coaching, and monitoring.

Form Health: Provides personalized weight loss plans supervised by physicians, integrating medication and lifestyle changes.

Found: Focuses on weight care through a combination of medication, coaching, and community support.

True You Weight Loss: Specializes in non-surgical weight loss procedures, including gastric balloons and endoscopic sleeve gastroplasty.

These competitors emphasize personalized care, technological integration, and minimally invasive procedures, similar to Bariendo's offerings.

Strategic Collaborations and Partnerships

Bariendo has established significant collaborations to enhance its service delivery:

Scientific Advisory Board: Includes leading bariatric endoscopists such as Dr. Christopher C. Thompson and Dr. Pichamol "Sigh" Jirapinyo, ensuring adherence to best practices and innovative care.

Procedure Locations: Partners with top-tier medical facilities across various states, including Florida, New York, Texas, Michigan, South Carolina, and Washington D.C., to provide accessible and high-quality care.

Operational Insights

Bariendo's strategic considerations include:

Standardization of Procedures: Ensuring consistent quality and outcomes by adhering to best practices in ESG procedures.

Patient-Centric Approach: Offering personalized care plans, transparent pricing, and comprehensive support to enhance patient satisfaction and success rates.

Technological Integration: Utilizing remote monitoring and smart applications to provide continuous support and track patient progress effectively.

Strategic Opportunities and Future Directions

Bariendo's strategic roadmap includes:

Expansion of Service Offerings: Introducing additional non-surgical weight loss solutions and enhancing existing programs to cater to a broader patient base.

Geographical Growth: Extending partnerships with medical facilities to increase accessibility across more regions.

Technological Advancements: Investing in research and development to innovate and improve weight loss procedures and patient monitoring systems.

Educational Initiatives: Providing training and resources to healthcare professionals to promote best practices in non-surgical weight loss interventions.

Contact Information

Website: www.bariendo.com

Social Media:

Facebook: Bariendo Facebook

YouTube: Bariendo YouTube

Bariendo's commitment to innovation, patient-centered care, and collaboration with leading medical professionals positions it as a prominent player in the non-surgical weight loss industry.